Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.

Borràs N, Orriols G, Batlle J, Pérez-Rodríguez A, Fidalgo T, Martinho P, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Parra R, Altisent C, Cid AR, Bonanad S, Cabrera N, Moret A, Mingot-Castellano ME, Navarro N, Pérez-Montes R, Marcellin S, Moreto A, Herrero S, Soto I, Fernández-Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés-Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Quismondo NC, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Vidal F, Corrales I.

Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25.

2.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Pérez-Rodríguez A, Batlle J, Corrales I, Borràs N, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Batlle F, Vidal F, López-Fernández MF.

PLoS One. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876. eCollection 2018.

3.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.

Borràs N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Vidal F, Corrales I.

Haematologica. 2017 Dec;102(12):2005-2014. doi: 10.3324/haematol.2017.168765. Epub 2017 Sep 29.

4.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.

Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F.

Thromb Haemost. 2016 Jan;115(1):40-50. doi: 10.1160/TH15-04-0282. Epub 2015 Aug 6.

PMID:
26245874
5.

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

García-Dasí M, Aznar JA, Jiménez-Yuste V, Altisent C, Bonanad S, Mingot E, Lucía F, Giménez F, López MF, Marco P, Pérez R, Fernández MÁ, Paloma MJ, Galmes B, Herrero S, García-Talavera JA.

Haemophilia. 2015 Jul;21(4):458-64. doi: 10.1111/hae.12618. Epub 2015 Feb 4.

PMID:
25649244
6.

Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states.

López Y, Paloma MJ, Rifón J, Cuesta B, Páramo JA.

Thromb Res. 1999 Jan 15;93(2):71-8.

8.

[Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].

Prósper F, Paloma MJ, Rifón J, Cuesta B, Hermida J, Rocha E.

Sangre (Barc). 1993 Dec;38(6):497-9. Review. Spanish.

PMID:
8171387
9.

[Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].

Paloma MJ, Páramo JA, Rifón J, Rocha E.

Sangre (Barc). 1992 Dec;37(6):435-8. Spanish.

PMID:
1293794
10.

Effect of DDAVP on endotoxin-induced intravascular coagulation in rabbits.

Paloma MJ, Páramo JA, Rocha E.

Thromb Haemost. 1992 Sep 7;68(3):306-9.

11.

Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.

Páramo JA, Rifón J, Llorens R, Casares J, Paloma MJ, Rocha E.

Haemostasis. 1991;21(1):58-64.

PMID:
1907591
12.

[Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].

Páramo JA, Fernández FJ, Cuesta B, Paloma MJ, Rocha E.

Sangre (Barc). 1989 Aug;34(4):297-9. Review. Spanish. No abstract available.

PMID:
2505395
13.

Clotting activation and impairment of fibrinolysis in malignancy.

Rocha E, Páramo JA, Fernández FJ, Cuesta B, Hernández M, Paloma MJ, Rifón J.

Thromb Res. 1989 Jun 15;54(6):699-707.

14.

[Coagulation inhibitors in patients with neoplasms].

Páramo JA, Cuesta B, Hernández M, Fernández J, Paloma MJ, Rifón J, Rocha E.

Med Clin (Barc). 1989 Feb 11;92(5):164-6. Spanish.

PMID:
2524631
15.

[Thrombosis and hypercoagulable states].

Páramo JA, Cuesta B, Fernández J, Alfaro MJ, Paloma MJ, Rocha E.

Rev Med Univ Navarra. 1987 Oct-Dec;31(4):233-7. Review. Spanish. No abstract available.

PMID:
3327132
16.

[New thrombolytic agents: present and future].

Páramo JA, Fernández J, Cuesta B, Aranda A, Paloma MJ, Rocha E.

Rev Med Univ Navarra. 1987 Oct-Dec;31(4):225-30. Review. Spanish. No abstract available.

PMID:
3327131

Supplemental Content

Loading ...
Support Center